Back
BridgeBio Pharma Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
BBIO
BridgeBio Pharma
Last Price:
$46.94
Seasonality Move:
8.94%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing slight selling pressure.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.99 | Buy |
20-day SMA: | 43.48 | Buy |
50-day SMA: | 38.84 | Buy |
200-day SMA: | 32.22 | Buy |
8-day EMA: | 45.5 | Buy |
20-day EMA: | 43.43 | Buy |
50-day EMA: | 40.11 | Buy |
200-day EMA: | 34.1 | Buy |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.19 | Buy |
Relative Strength Index (14 RSI): | 74.66 | Buy |
Chaikin Money Flow: | -196344 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.05 - 45.23) | Buy |
Bollinger Bands (100): | (32.44 - 40.64) | Buy |
BridgeBio Pharma Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 47.69 while BBIO 8-day simple moving average is 44.99, which is a Buy signal.
-
The stock price of BBIO is 47.69 while BridgeBio Pharma 20-day SMA is 43.48, which makes it a Buy.
-
BridgeBio Pharma 50-day simple moving average is 38.84 while BBIO share price is 47.69, making it a Buy technically.
-
BBIO stock price is 47.69 and BridgeBio Pharma 200-day simple moving average is 32.22, creating a Buy signal.
BBIO Technical Analysis vs Fundamental Analysis
Buy
55
BridgeBio Pharma (BBIO)
is a Buy
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a BuyThe current BridgeBio Pharma [BBIO] share price is $47.69. The Score for BBIO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
9.1B
Price in USD:
47.69
Share Volume:
3.9M
BridgeBio Pharma 52-Week Range
52-Week High:
48.68
52-Week Low:
21.72
Buy
55
BridgeBio Pharma (BBIO)
is a Buy
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?The BridgeBio Pharma stock price is 47.69 USD today.
-
Will BBIO stock go up or go down?BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is BridgeBio Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is not overvalued.
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 47.69 while BBIO 8-day exponential moving average is 45.50, which is a Buy signal.
-
The stock price of BBIO is 47.69 while BridgeBio Pharma 20-day EMA is 43.43, which makes it a Buy.
-
BridgeBio Pharma 50-day exponential moving average is 40.11 while BBIO share price is 47.69, making it a Buy technically.
-
BBIO stock price is 47.69 and BridgeBio Pharma 200-day simple moving average is 34.10, creating a Buy signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.19 per share, an increase this year of $0.17 per share, and an increase next year of $0.47 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
-
BBIO Moving Average Covergence Divergence (MACD) indicator is 2.19, suggesting BridgeBio Pharma is a Buy
-
BridgeBio Pharma Relative Strength Index (RSI) is 74.66, which suggest BridgeBio Pharma is overbought
-
The Bollinger Bands (25) for BridgeBio Pharma is (40.05 - 45.23), which suggest BridgeBio Pharma is a Buy
-
The Bollinger Bands (100) for BridgeBio Pharma is (32.44 - 40.64), which suggest BridgeBio Pharma is a Buy
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.